Other Clinical Trial - Post-Marketing Study Of The Safety Of Tygacil

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Completed

Clinical Trial Summary

The purpose of this study is to collect post-marketing information on the safety of Tygacil in Filipino patients.

Three-thousand or 10% of total number of patients given tigecycline will be included in the study ;

Observational Model: Case-Only, Time Perspective: Prospective

See also
Status	Clinical Trial	Phase
Completed	`NCT00389987` - Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)	Phase 3
Completed	`NCT02784704` - Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections	Phase 3
Completed	`NCT01072539` - Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Completed	`NCT00752219` - Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections	Phase 2
Completed	`NCT03830333` - Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)	Phase 3
Not yet recruiting	`NCT03678298` - Italian Register for the Study of Complicated Intra-Abdominal Infections
Active, not recruiting	`NCT00860587` - Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections	N/A
Completed	`NCT01844856` - Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections	Phase 3
Completed	`NCT02475733` - Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).	Phase 2